Apelin/APJ System: a Novel Promising Therapy Target for Thrombotic Diseases.

Lanfang Li,Jin Xu,Linxi Chen,Zhisheng Jiang
DOI: https://doi.org/10.1093/abbs/gmw028
IF: 3.7
2016-01-01
Acta Biochimica et Biophysica Sinica
Abstract:APJ, which was initially identi fi ed as a gene with closest homology to the angiotensin II type 1 receptor, is a seven transmembrane G protein-coupled receptor. Apelin is an endogenous ligand of the APJ originally isolated from bovine stomach extracts. There are several isoforms of apelin. Apelin preproproteins contain 77 amino-acid residues, which can be cleaved to form shorter bioactive isoforms, including apelin-36, apelin-17, apelin-13, apelin-12, and so on. Apelin/APJ receptor is extensively distributed in the central nervous system and peripheral tissues. Apelin/APJ system involves in a wide range of physiological and pathological functions. For example, apelin lowers blood pressure via a NO/cGMP-dependent mechanism. Apelin-13 maintains the Ca 2 + transient against ischemia/reperfusion in cardiomyocytes. Furthermore, apelin-13 promotes cell proliferation and angiogenesis via PI3K/AKT activation It is that
What problem does this paper attempt to address?